GE Healthcare Shares Rise on Strong Order Growth and Improved Guidance
Shares in GE Healthcare rose by over 11% following its second-quarter earnings report, which showed better-than-expected results. Despite a challenging year marked by rising costs from memory chips, oil, freight, and raw materials, the company reported an increase in orders with a book-to-bill ratio of 1.15 times and a backlog reaching $23.9 billion. The growth in orders suggests improving pricing power for GE Healthcare, which had previously cut its full-year guidance due to cost pressures. CFO James Saccaro noted that the company's cost management efforts are stabilizing, with expected contributions to margins later this year and into 2027. CEO Peter Arduini highlighted new product launches featuring embedded AI as a driver for future pricing improvements. The market is responding positively to these developments, signaling confidence in GE Healthcare’s ability to overcome recent challenges and improve revenue and margin performance.
Tickers: $GEHC
Topics: Cost Management Earnings Order Growth